SBIR-STTR Award

Long-Term Broad-Spectrum Prevention of Implant-Related Infections
Award last edited on: 10/11/19

Sponsored Program
STTR
Awarding Agency
NIH : NIA
Total Award Amount
$162,266
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Phyllis B Siegel

Company Information

Biomedical Development Corporation

620 East Dewey Place
San Antonio, TX 78212
   (210) 308-0636
   bdc@biodevcorp.com
   www.biodevcorp.com

Research Institution

University of Texas - San Antonio

Phase I

Contract Number: 1R41AG044960-01
Start Date: 9/30/12    Completed: 8/31/13
Phase I year
2012
Phase I Amount
$162,266
Deep wound infection following total joint arthroplasty is a devastating complication for physician and patient, a leading cause of morbidity, and a significant economic burden to the healthcare system. With an aging population and increased life expectancies, the number of arthroplasties is expected to rise dramatically over the next 20 years. The growing number of high-risk patients undergoing surgery further increases the severity of septic complications and other adverse outcomes. Antibiotics have been incorporated into bone cement for prophylaxis and orthopedic applications for more than 30 years. However, antibiotic laden bone cement is not generally indicated for prophylactic use due to concerns about cost, long-term mechanical performance, and most importantly, the potential for developing antibiotic resistance. As an antimicrobial agent, silver has been extensively researched because of its exceptional safety and efficacy. Further, the risk of silver inducing widespread bacterial resistance is considered to be remote. Recently, the incorporation of silver nanoparticles (AgNP) into medical devices has been investigated, but problems encountered with homogeneously dispersing AgNPs into biomaterials and the need for complex processes and harsh chemicals required for synthesis have limited its use. Researchers at the University of Texas Health Science Center at San Antonio have recently developed an innovative single-step method to synthesize AgNPs in situ in acrylic resins such as polymethylmethacrylate (PMMA) that requires no harsh chemicals. Preliminary studies show that this material possesses mechanical properties comparable to resins without AgNPs, while demonstrating well-distributed AgNPs that provide extended release of Ag+ ions that are biocidal to several pathogens. Thus, the goal of this project is to develop a long-lasting, broad-spectrum, antimicrobial bone cement using this novel method to generate AgNPs in situ. This Phase I study has five Specific Aims: Specific Aim 1. Formulation and Evaluation of Mechanical Properties Specific Aim 2. In Vitro Ag+ Ion Release Specific Aim 3. In Vitro Antimicrobial Activity Specific Aim 4. Biocompatibility Specific Aim 5. Fatigue Testing

Public Health Relevance:
Infection following total knee and total hip replacement surgery is a devastating complication for patients and very costly to the healthcare system. Antibiotics can be incorporated into bone cement to reduce infection, but are generally not used preventively because they can adversely impact the mechanical properties of the cement, are expensive, and can cause drug resistance where a microorganism is able to survive exposure to the antibiotic. The development of a safe and effective antimicrobial bone cement containing silver nanoparticles that would not induce drug resistance and would overcome the limitations of current products would have a significant impact on public health.

Public Health Relevance Statement:
Infection following total knee and total hip replacement surgery is a devastating complication for patients and very costly to the healthcare system. Antibiotics can be incorporated into bone cement to reduce infection, but are generally not used preventively because they can adversely impact the mechanical properties of the cement, are expensive, and can cause drug resistance where a microorganism is able to survive exposure to the antibiotic. The development of a safe and effective antimicrobial bone cement containing silver nanoparticles that would not induce drug resistance and would overcome the limitations of current products would have a significant impact on public health.

NIH Spending Category:
Aging; Antimicrobial Resistance; Bioengineering; Emerging Infectious Diseases; Infectious Diseases; Nanotechnology; Prevention

Project Terms:
absorption; Acinetobacter baumannii; Acrylic Resins; adverse outcome; aging population; Antibiotic Resistance; Antibiotics; antimicrobial; antimicrobial drug; Area; Arthroplasty; bacterial resistance; bactericide; Biocompatible Materials; biomaterial compatibility; Biomedical Engineering; Bone Cements; Chemicals; Clinical; commercialization; Complex; Complication; cost; cytotoxicity; Data; density; Development; Devices; Doctor of Medicine; Doctor of Philosophy; Drug Formulations; Drug resistance; Economic Burden; efficacy evaluation; Engineering; Ensure; Evaluation; Exposure to; Fatigue; FDA approved; Free Radicals; Future; Goals; Hardness; Health Sciences; Healthcare; Healthcare Systems; high risk; Implant; implantation; In Situ; In Vitro; in vivo; Infection; innovation; Intramuscular; Ions; Joints; Knee; Lead; Legal patent; Libraries; Life; Life Expectancy; Materials Testing; Measures; Mechanics; Medical Device; methicillin resistant Staphylococcus aureus (organism); Methods; microorganism; Modeling; Morbidity - disease rate; nanoparticle; nanoparticulate; novel; Operative Surgical Procedures; Orthopedics; Oryctolagus cuniculus; pathogen; Patients; Performance; phase 1 study; Physicians; Plant Resins; polymerization; Polymers; Polymethyl Methacrylate; Porosity; prevent; Prevention; Preventive; Principal Investigator; Process; Production; Property; prophylactic; Prophylactic treatment; Pseudomonas aeruginosa; public health medicine (field); Reducing Agents; Regulation; Reproducibility; Research; Research Personnel; Risk; Safety; Sampling; scale up; Scientist; septic; Severities; Silver; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Stabilizing Agents; Staging; Surface; System; Technology; Tensile Strength; Testing; Texas; Total Hip Replacement; Universities; Water; Wound Infection

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----